- Home
- DSWL vs CNTX Comparison
DSWL vs CNTX Comparison
Compare DSWL & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSWL
- CNTX
- Stock Information
- Founded
- DSWL 1987
- CNTX 2015
- Country
- DSWL Macau
- CNTX United States
- Employees
- DSWL N/A
- CNTX N/A
- Industry
- DSWL Plastic Products
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- DSWL Industrials
- CNTX Health Care
- Exchange
- DSWL Nasdaq
- CNTX Nasdaq
- Market Cap
- DSWL 64.1M
- CNTX 75.6M
- IPO Year
- DSWL 1995
- CNTX 2021
- Fundamental
- Price
- DSWL $3.96
- CNTX $0.88
- Analyst Decision
- DSWL
- CNTX Strong Buy
- Analyst Count
- DSWL 0
- CNTX 5
- Target Price
- DSWL N/A
- CNTX $5.25
- AVG Volume (30 Days)
- DSWL 43.6K
- CNTX 86.7K
- Earning Date
- DSWL 11-14-2025
- CNTX 11-05-2025
- Dividend Yield
- DSWL 5.03%
- CNTX N/A
- EPS Growth
- DSWL 45.62
- CNTX N/A
- EPS
- DSWL 0.70
- CNTX N/A
- Revenue
- DSWL $67,610,000.00
- CNTX N/A
- Revenue This Year
- DSWL N/A
- CNTX N/A
- Revenue Next Year
- DSWL N/A
- CNTX N/A
- P/E Ratio
- DSWL $5.56
- CNTX N/A
- Revenue Growth
- DSWL N/A
- CNTX N/A
- 52 Week Low
- DSWL $1.93
- CNTX $0.49
- 52 Week High
- DSWL $4.48
- CNTX $2.59
- Technical
- Relative Strength Index (RSI)
- DSWL 56.57
- CNTX 60.55
- Support Level
- DSWL $3.80
- CNTX $0.81
- Resistance Level
- DSWL $4.40
- CNTX $0.87
- Average True Range (ATR)
- DSWL 0.21
- CNTX 0.04
- MACD
- DSWL -0.05
- CNTX -0.00
- Stochastic Oscillator
- DSWL 28.77
- CNTX 74.71
About DSWL Deswell Industries Inc.
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.